| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SR8278 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.3 |
| mRNA | BRD6340 | CTRPv2 | pan-cancer | AAC | -0.033 | 0.3 |
| mRNA | SNX-2112 | CTRPv2 | pan-cancer | AAC | 0.03 | 0.3 |
| mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | 0.029 | 0.3 |
| mRNA | BRD-K79669418 | CTRPv2 | pan-cancer | AAC | -0.05 | 0.3 |
| mRNA | YL54 | CTRPv2 | pan-cancer | AAC | -0.037 | 0.3 |
| mRNA | BRD-K49290616 | CTRPv2 | pan-cancer | AAC | -0.08 | 0.3 |
| mRNA | GSK4112 | CTRPv2 | pan-cancer | AAC | -0.035 | 0.3 |
| mRNA | GW-405833 | CTRPv2 | pan-cancer | AAC | -0.032 | 0.3 |
| mRNA | JQ-1:vorinostat (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.031 | 0.3 |